HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

2.2%

0.3%

5.1%

6.2%

6.4%

15.3%

20.0%

10y

6.9%

all

8.8%

🤔 How to analyze this graph?

Last Traded Price

₹ 217 2.2%

174

252

Company Overview

Sales

1,735 Cr

Growth: -4.1%

Profit after Tax

-42.7 Cr

Growth: -12.5%

Small Cap

2,680 Cr

P/S: 1.5x

Industry P/S: 2.7x

Fundamentals

Sales (Cr)	₹ 1,735
Growth	-4.1%
EBITDA	13.4%
P/S	1.5x
Dividend	0.4%
P/E	-79.3x
Book Value	₹ 95.9
PEG Ratio	18.9x
ROE	-3.6%
P/B	2.2x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (9 Indices) view more

Investors (64)

sugandha...

idfc.ste...

bf.inves...

Followers (6)

mike2

nitin29

vishal48